PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1273478
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1273478
The sternal closure systems market is projected to grow with a CAGR of nearly 5.3% over the forecast period.
COVID-19 significantly impacted the growth of the sternal closure systems market due to the strict lockdown regulations and poor supply of sternal closure products during the initial stages of the pandemic. Also, healthcare providers were occupied with COVID-19 patients, access was restricted to only essential care, and the temporary shutdown of cardiology centers significantly curtailed sternal procedures. According to the BMC study published in March 2021, a worldwide survey identified cardiac surgery reduced by 50% to 75% during the pandemic, with a 50% reduction in dedicated cardiac theater rooms and Intensive care unit beds in 2020. Thus, the significant impact on cardiac surgeries also had a notable impact on the sternal closure system, affecting the market's growth. Moreover, owing to the resumption of elective surgeries after the relaxations of regulations in the post-pandemic period
The major factor attributed to the market growth is the increasing number of open-heart surgeries, along with the rising geriatric population worldwide. For instance, the NIH article published in June 2022 mentioned that more than 2 million people worldwide have open-heart surgery each year to treat various heart problems. Such a high volume of open heart surgeries is expected to drive the demand for sternal closure systems as they are widely used in open heart surgeries to rejoin the sternum, thereby contributing to market growth over the forecast period. Moreover, according to the WHO report published in October 2022, the share of the population in the world aged 60 years and over will increase to 1.4 billion by 2030 and reach 2.1 billion by 2050. Thus, the increasing geriatric population, more susceptible to developing cardiovascular diseases and often requiring open heart surgeries, is expected to contribute to the market growth over the forecast period.
Furthermore, rising product approvals are also expected to contribute to the market's growth. For instance, in October 2021, Able Medical Devices received 510(k) clearance from the United States Food and Drug Administration for its Valkyrie Thoracic Fixation System, which is used for chest wall fracture stabilization, including sternal fixation after sternotomy and sternal reconstructive surgical procedures for patients with normal and poor bone.
Thus, the increasing number of open heart surgeries, the rising geriatric population, and increasing product developments are expected to contribute to the market's growth. However, the gaining popularity of alternative procedures is expected to restrain the market's growth over the forecast period.
Sternal closure with wires has become the standard because of the ease of use, speed of use, relatively low complication rate, and low cost of wires. Common closure methods use either interrupted or figure-of-eight wires to secure the sternal halves created during the median sternotomy. All wiring techniques, however, allow some movement and separation of sternal halves under physiologic loads. These minimal movements do not cause problems in most patients with healthy sternums unless the sternotomy is technically faulty. They may even promote faster bone healing by stimulating early callus formation.
The factors propelling the segment growth are increasing heart surgeries, the geriatric population, and the rising product developments by various key market players. For instance, the NCBI article published in August 2022 mentioned that almost 400,000 coronary artery bypass grafting surgeries are performed each year across the world. Similarly, according to the article published by NCBI in August 2022, approximately 29,947 isolated coronary artery bypass grafting procedures, 36,714 isolated heart valve procedures, and 750 assist device implantations were registered in Germany in 2021. Thus, the rising number of heart surgeries, among which the sternal closure wires are highly used in surgical procedures, are also expected to contribute to the growth of the studied segment.
On the other hand, the rising adoption of sternal closure wires due to their high efficiency in sternal closure procedures is expected to contribute to the market's growth. For instance, according to the NCBI study published in May 2022, stainless steel cerclage wires remain the most well-known and widely utilized sternal fixation technique. Hence, the growing utilization of wire products in the sternal closure is expected to drive segment growth over the forecast period.
Thus, the factors above are boosting the market segment's growth over the forecast period.
North America is expected to hold the major share of the overall market, throughout the forecast period. The factors that are expected to contribute to the growth of the market in this region are the rising number of open-heart and coronary artery bypass grafting surgeries, the increasing geriatric population along with the advanced healthcare infrastructure.
For instance, as per the data published by Detroit Medical Center in 2022, approximately 500,000 people undergo open-heart surgery each year in the United States. Also, the data published by the New Jersey Department of Health in August 2022, there were 17,291 open heart surgeries in New Jersey in 2021. Similarly, the article published in NCBI article in May 2021 reported that about 15,000 people in Canada undergo coronary artery bypass grafting surgery each year. Furthermore, the rising geriatric population among the North American countries who are prone to cardiac disorders and in need of cardiac surgeries is also expected to drive the demand for sternal closure systems, thereby fueling the market growth. For instance, according to Statistics Canada, the senior population in Canada reached 2,308,041 in 2022, from 2,232,871 in 2021. Likewise, the UCAM data published in 2022, around 12% of the total Mexican population is over 60 years and older. Thus, the growing geriatric population in the region is expected to boost market growth over the forecast period.
Therefore, owing to the above-mentioned factors, the rising cardiac surgeries, the increasing geriatric population along with the presence of key market players in the North American region are expected to occupy a major share of the sternal closure system market during the forecast period of the study.
The Sternal Closure Systems market is moderately competitive and has several major players. Some companies currently dominating the market are Johnson & Johnson, Zimmer Biomet Holdings, KLS Martin Group, Acumed, LLC (Colson Medical, LLC), A&E Medical, Idear S.R.L, Praesidia SRL, Kinamed Incorporated, etc.